confusion, diaphoresis, lacrimation, marked muscle fasciculations, unreactive miosis and respiratory distress. He remained haemodynamically stable and well per fused with no localising chest signs and no ECG changes apart from sinus tachycardia.
He was intubated and gastric lavage was performed. The patient was commenced on an atropine infusion 3.6 mg/hour and transferred to ITU for ventilation and monitoring. Approximately four hours after the documented ingestion a P AM infusion (pyridium-2-aldoxime methyliodide in sterile water) of 2 g over 10 minutes was begun. After two minutes the patient suffered a cardiac arrest in asystole. He responded rapidly to intravenous sodium bicarbonate and adrenaline. The PAM infusion was recommenced but within two minutes the patient had a further cardiac arrest in asystole. Intracardiac adrenaline produced ventricular fibrillation which responded to DC countershock. He was continued on the atropine infusion only. Thin layer chromatography toxicology screen later demonstrated large amounts of coumophos, small amounts of trifluperazine and chlorpromazine and their metabolites.
Intravenous atropine (0.6 mg per 5-30 minutes) was adjusted specifically to prevent endobronchial secretions and sialorrhoea rather than produce mydriasis or improve bradycardia. By Day 3 his conscious state improved and he became restless and appeared to be hallucinating. The atropine infusion was reduced to improve his psychosis. With no significant rise in cholinesterase levels by Day 5 and in expectation of extended ventilation a tracheostomy was performed.
His enzyme levels improved gradually after 18 days with concomitant return of muscle power. His atropine infusion was reduced stepwise and he was weaned from the ventilator and later discharged to the ward on Day 22.
DISCUSSION
Historically the most comprehensive work on management of organophosphate insecticide poisoning came from Malaya and a recent publication from the University Hospital, Kuala Lumpur' detailed a retrospective study of 100 cases managed using only atropine, P AM having not been used since in vitro studies with human sera by Ganendran et al. in 1975 confirmed the clinical impression that PAM made no significant improvement in the outcome overalF and indeed in some types of organophosphate poisoning risked the danger of producing more potent phosphonylated oximes. 3 Sudden cardiac arrest following repeated challenge with P AM for massive organophosphate poisoning has not been documented previously. Known adverse effects are nonspecific and include drowsiness, dizziness, disturbances of vision, nausea, tachycardia, headache, hyperventilation and muscle weakness. The clinical details of this case do not suggest reaction to the iodine in P AM particularly since the patient had subsequent uneventful topical applications of iodine and a later intra-operative cholangiogram.
Minor tranquillisers are known to cause widened QRS complexes, prolonged QT intervals, ventricular arrhythmia and sudden death, and there is at least one reported fatality presumed due to potentiation of the effects of an organophosphate poison by the phenothiazine promazine. 4 To postulate the mechanism for the observed synergism of organophosphate toxicity, several antihistaminic phenothiazine compounds have been shown to inhibit human butyrylcholinesterase in vitro. 5 Ganendran demonstrated a dramatic deterioration on butylcholinesterase activity in vivo which necessitated reintroduction of ventilation in a Anaesthesia and intensive Care, Vol. 14, No. 4, November, 1986 patient with organophosphate poisoning who was given chlorpromazine and diazepam to control restlessness. 6 Bradycardia and hypotension are known adverse cardiac effects of cholinesterase inhibitors with reports of asystole following the use of edrophonium to convert or diagnose supraventricular arrhythmia.? The ventricular conducting system has been shown to have abundant cholinergic innervation. 8 Case reports in the Annals of Emergency Medicine described two patients with tricyclic antidepressant toxicity who developed bradycardia and subsequent asystole following the administration of physostigmine to treat seizures. 9 In both cases the administration of atropine preceded the development of asystole by not more than two minutes. Bradycardia has been observed within minutes following low dose atropine lO presumably due to stimulation of the medullary cardio-inhibitory centre. The transient fall in heart rate disappears as soon as peripheral muscarinic blockade is fully established.
In summary this patient's successful management was based on airway maintenance, ventilation, antibiotic cover and continuous high-dose intravenous atropine. The time-honoured eminence of P AM as an antidote in organophosphate poisoning is undeserved. It has been shown not to improve the overall prognosis, its use potentially delays the appropriate introduction of atropine and in this patient's case very nearly led to a fatal drug interaction. PAM has no place in the current management of organophosphate poisoning.
Over the past few years, we have encountered several patients who have exhibited varying degrees of neck swelling and upper airway obstruction following carotid endarterectomy. In many cases this has resulted in near fatal outcomes upon the administration of general anaesthesia for the re-exploration of the wound.
Practising anaesthetists are aware of the potential anaesthetic problems which may present in those patients with some form of compromise to the upper airway. However this problem in this group of patients has not only been poorly recognised but to a large extent underestimated. We therefore present six cases in which postoperative swelling of the neck was associated with unexpected difficulty in airway management. Intra-luminal shunting was not used during the procedure and drainage tubes were not inserted into the wound. Ninety minutes after extubation it was noticed that there was significant swelling of the right side of the neck. Over the next two hours this swelling increased dramatically in size and spread to the left side. With this increasing swelling she developed stridor which was not relieved by removal of wound sutures on both sides, and emergency re-intubation was decided upon. She was preoxygenated, and then given diazepam 5 mg and suxamethonium 100 mg intravenously.
Following the administration of suxamethonium it was impossible to ventilate the patient. Direct laryngoscopy revealed folds of mucosa which completely obliterated all normally recognisable landmarks in the upper airway. The patient became deeply cyanosed and developed an extreme bradycardia of less than 10 beats per minute. Just as an emergency
